Evaluation of the Variation of the Sub-pulmonary Velocity-time Integral to Predict Fluid Responsiveness
NCT ID: NCT07202637
Last Updated: 2025-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
205 participants
OBSERVATIONAL
2024-11-07
2027-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Time Course Evolution of Cardiac Output
NCT03694717
Fluid Responsiveness Prediction at the Bedside
NCT00721604
Passive Leg Raise and Mini-fluid Challenge Effect on Various Cardiac Output Surrogates for Fluid Responsiveness
NCT06390423
End-expiratory Occlusion Test and Prediction of Preload Dependence
NCT05874531
Hemodynamic Monitoring and Fluid Responsiveness in Venovenous Extracorporeal Membrane Oxygenation (VV ECMO) - "HemodynamECMOnitoring-VV Study"
NCT06593717
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients suspected of hypovolemia
Patients with suspected hypovolemia who need to be evaluated for fluid responsiveness
Fluid bolus administration
Fluid infusion of 500 mL of a crystalloïd solution is performed for patients with signs of hypovolemia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fluid bolus administration
Fluid infusion of 500 mL of a crystalloïd solution is performed for patients with signs of hypovolemia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with measurable sub-aortic VTI in apical 4-chamber view before and after PLR maneuver.
* Patient with suspected hypovolemia or whose hemodynamic status justifies vasopressor infusion.
Exclusion Criteria
* Severe right ventricular dysfunction defined by TAPSE \< 12 mm.
* Cardiac arrhythmia or atrial fibrillation.
* Abdominal compartment syndrome.
* Amputation of one or both lower limbs.
* Intracranial hypertension.
* Pregnant women (ruled out by systematic pregnancy test at ICU admission).
* Minors.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Nord
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gary DUCLOS
MD, MSc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de réanimation polyvalente - Hopital Nord
Marseille 15, , France
Hopital Caremeau Nimes
Nîmes, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A02636-39
Identifier Type: OTHER
Identifier Source: secondary_id
ITV-VD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.